- Posted on 1 Sep 2022
- 1-minute read
Features include:
- Estimating potential cost-effectiveness of pancreatic cancer screening in patients with new-onset diabetes (CHERE)
- Australasian Gastro-Intestinal Trials Group (AGITG)
- Australasian Leukaemia and Lymphoma Group (ALLG)
- Australia New Zealand Gynaecological Oncology Group (ANZGOG)
- Cost-effectiveness of single vs multifraction SABR for pulmonary oligometastases: The SAFRON-II Trial (CHERE)
- Australian & New Zealand Urogenital and Prostate (ANZUP)
- Breast Cancer Trials (BCT)
- Cancer Quality of Life Expert Service Team (CQUEST)
- Cancer Symptom Trials (CST)
- QUOKKA Research Program: Quality of life in kids, key evidence to strengthen decisions in Australia
- CREST Health Economics Workshop
- CREST Monthly Drop-In Health Economics Clinics